GXD · Class II · 21 CFR 882.4400

FDA Product Code GXD: Generator, Lesion, Radiofrequency

Leading manufacturers include Abbott Medical, Rf Innovations, Inc. and Neuroone Medical Technologies Corp..

37
Total
37
Cleared
200d
Avg days
1991
Since
Growing category - 3 submissions in the last 2 years vs 2 in the prior period
Review times improving: avg 135d recently vs 206d historically

FDA 510(k) Cleared Generator, Lesion, Radiofrequency Devices (Product Code GXD)

37 devices
1–24 of 37

About Product Code GXD - Regulatory Context

510(k) Submission Activity

37 total 510(k) submissions under product code GXD since 1991, with 37 receiving FDA clearance (average review time: 200 days).

Submission volume has increased in recent years - 3 submissions in the last 24 months compared to 2 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under GXD have taken an average of 135 days to reach a decision - down from 206 days historically, suggesting improved FDA processing for this classification.

GXD devices are reviewed by the Neurology panel. Browse all Neurology devices →